Remove healthcare-authority
article thumbnail

AI ushers in next-gen prior authorization in healthcare

Mckinsey and Company

Healthcare payers recognize that prior authorization (PA) is ripe for improvement. AI-enabled PA design may deliver substantial financial, user-experience, and care benefits.

19
article thumbnail

Watchdog fears healthcare tech merger could push up NHS costs

The Guardian M&A

CMA gives UnitedHealth and EMIS five working days to tackle concerns over £1.2bn deal The competition watchdog has warned that a proposed merger between two healthcare technology specialists would lead to higher costs and “worse outcomes for the NHS and ultimately patients and UK taxpayers”.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Benchmark International Successfully Facilitated the Transaction Between South West Intervention Services Limited and Tristone Healthcare Limited

Benchmark Report

SWIS is a care provider that collaborates with local authorities and educational institutions to provide young people with support and intervention programmes tailored to each individual’s personal needs.

52
article thumbnail

PharmAla Biotech Nabs First-Ever Canadian Approval To Provide MDMA Treatment Outside Clinical Setting

Benzinga

The federal agency has confirmed that this is the first-ever authorization of an MDMA-assisted therapy treatment under the SAP. See also: Psychedelic Therapies Soon Available In Australia Via Incannex Healthcare And Subsidiary The partnership will not charge. Full story available on Benzinga.com

article thumbnail

Dynacare Acquires Valley Medical Laboratories

Benzinga

The combined strength of Dynacare and Valley Medical will offer an expansive patient service centre network and diagnostic test menu to patients, customers, and the healthcare community. Brampton, Ont., Full story available on Benzinga.com

40
article thumbnail

IVSC Webinars Series 2023 – Bios

IVSC

She has been involved in multiple valuation assignments for a wide range of industries, including pharma, biotech, healthcare, vitamin retail, specialty chemicals, industrial manufacturing, and gaming and hospitality. She was also a contributing author to the chapter "Risk-Free Rate" in the fifth edition.

article thumbnail

Goodwin Procter Discusses DOJ Focus on False Claims Act Enforcement Against Private Equity

Reynolds Holding

billion related to matters involving the healthcare industry. After touting DOJ’s recent successes, Boynton previewed the Department’s enforcement priorities for 2024: (1) cybersecurity,(2) pandemic-related fraud, and (3) healthcare fraud. Boynton noted four areas of focus for the Department within healthcare.

Equity 45